Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Safety Reporting to Ethics Committees and IRBs

Posted on By

Standard Operating Procedure for Safety Reporting to Ethics Committees and Institutional Review Boards

Purpose

This SOP outlines the procedures for safety reporting to Ethics Committees and Institutional Review Boards (IRBs) in clinical trials and clinical studies. The goal is to ensure timely and accurate reporting of safety information to Ethics Committees and IRBs, in compliance with regulatory requirements and study protocols.

Scope

This SOP applies to all personnel involved in safety reporting in clinical trials and clinical studies, including principal investigators, clinical research coordinators, study sponsors, and safety reporting specialists.

Responsibilities

  • Principal Investigator (PI): Ensures the timely and accurate reporting of safety information to Ethics Committees and IRBs.
  • Clinical Research Coordinators: Assist in gathering and documenting safety information and preparing reports for submission.
  • Study Sponsors: Provide guidance and resources for safety reporting and compliance with regulations.
See also  SOP for Statistical Analysis and Data Interpretation

Procedure

  • Safety Information Collection:
    • Collect safety information from various sources, including adverse event reports, safety data from external sources, and literature reviews.
  • Assessment and Classification:
    • Assess safety information to determine its relevance and impact on study participants.
    • Classify safety information based on severity and seriousness, following regulatory definitions.
  • Preparation of Safety Reports:
    • Prepare safety reports according to regulatory requirements and study protocols.
    • Include relevant information such as the nature of the safety issue, potential impact, and any corrective actions taken.
  • Submission to
Ethics Committees and IRBs:
  • Submit safety reports to the relevant Ethics Committees and IRBs within the specified timeframes.
  • Provide additional information or follow-up as requested by Ethics Committees and IRBs.
  • Documentation and Record-Keeping:
    • Maintain records of safety reports, including submission dates, report content, and any correspondence with Ethics Committees and IRBs.
  • Feedback and Continuous Improvement:
    • Gather feedback from Ethics Committees and IRBs on the safety reporting process and reports.
    • Use feedback to improve future safety reporting and enhance study quality and safety.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • IRB: Institutional Review Board

    Documents

    • Safety reports
    • Correspondence with Ethics Committees and IRBs
    • Feedback from Ethics Committees and IRBs

    References

    • Regulatory guidelines for safety reporting to Ethics Committees and IRBs
    • Institutional policies for safety reporting

    SOP Version

    Version: 1.0

    See also  SOP for Participant Follow-Up and Retention
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Archiving and Long-Term Storage of Records
    Next Post: SOP for Use of Placebos and Comparator Products

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version